Liu J, Aliaga Goltsman D, Alexander L, Khayi K, Hong J, Dunham D
Nat Commun. 2025; 16(1):2427.
PMID: 40082411
PMC: 11906591.
DOI: 10.1038/s41467-025-57416-2.
Keneskhanova Z, McWilliam K, Cosentino R, Barcons-Simon A, Dobrynin A, Smith J
Nature. 2025; .
PMID: 40074895
DOI: 10.1038/s41586-025-08720-w.
Fioriniello S, Salzano A, Bifulco G, Aiese Cigliano R, Della Ragione F, Campanile G
Sci Rep. 2025; 15(1):8074.
PMID: 40057542
PMC: 11890600.
DOI: 10.1038/s41598-025-91969-y.
Scandino R, Nardone A, Casiraghi N, Galardi F, Genovese M, Romagnoli D
NPJ Breast Cancer. 2025; 11(1):25.
PMID: 40057527
PMC: 11890748.
DOI: 10.1038/s41523-025-00739-6.
Camargo S, Moskowitz O, Giladi A, Levinson M, Balaban R, Gola S
Nat Cancer. 2025; .
PMID: 40055573
DOI: 10.1038/s43018-025-00924-3.
Cryptic mitochondrial DNA mutations coincide with mid-late life and are pathophysiologically informative in single cells across tissues and species.
Green A, Klimm F, Marshall A, Leetmaa R, Aryaman J, Gomez-Duran A
Nat Commun. 2025; 16(1):2250.
PMID: 40050638
PMC: 11885543.
DOI: 10.1038/s41467-025-57286-8.
Retinitis pigmentosa-linked mutations impair the snRNA unwinding activity of SNRNP200 and reduce pre-mRNA binding of PRPF8.
Zimmann F, McNicoll F, Thakur P, Blazikova M, Kubovciak J, Hernandez Canas M
Cell Mol Life Sci. 2025; 82(1):103.
PMID: 40045025
PMC: 11883072.
DOI: 10.1007/s00018-025-05621-z.
Evolutionary fingerprints of epithelial-to-mesenchymal transition.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F
Nature. 2025; .
PMID: 40044861
DOI: 10.1038/s41586-025-08671-2.
Composition and RNA binding specificity of metazoan RNase MRP.
Liu Y, He S, Pyo A, Zheng S, Chen M, Cheloufi S
bioRxiv. 2025; .
PMID: 40027791
PMC: 11870539.
DOI: 10.1101/2025.02.21.639568.
Next-Generation Sequencing Methods to Determine the Accuracy of Retroviral Reverse Transcriptases: Advantages and Limitations.
Martinez Del Rio J, Menendez-Arias L
Viruses. 2025; 17(2).
PMID: 40006928
PMC: 11861041.
DOI: 10.3390/v17020173.
Re-Analyses of Samples From Amyotrophic Lateral Sclerosis Patients and Controls Identify Many Novel Small RNAs With Diagnostic And Prognostic Potential.
Loher P, Londin E, Ilieva H, Pasinelli P, Rigoutsos I
Mol Neurobiol. 2025; .
PMID: 39982687
DOI: 10.1007/s12035-025-04747-2.
Improved Quantification of Circulating Tumor DNA in Translocation-Associated Myxoid Liposarcoma by Simultaneous Detection of Breakpoints and Single Nucleotide Variants.
Schmid A, Lausch U, Runkel A, Kiefer J, Pauli T, Boerries M
Cancer Med. 2025; 14(4):e70704.
PMID: 39980272
PMC: 11842865.
DOI: 10.1002/cam4.70704.
Identification of molecular determinants of gene-specific bursting patterns by high-throughput imaging screens.
Sood V, Holewinski R, Andresson T, Larson D, Misteli T
Mol Cell. 2025; 85(5):913-928.e8.
PMID: 39978338
PMC: 11890955.
DOI: 10.1016/j.molcel.2025.01.022.
Sources of non-uniform coverage in short-read RNA-Seq data.
Brooks T, Lahens N, Mrcela A, Yang J, Purohit S, Naik A
bioRxiv. 2025; .
PMID: 39975309
PMC: 11838458.
DOI: 10.1101/2025.01.30.634337.
Functional analysis of cancer-associated germline risk variants.
Kellman L, Neela P, Srinivasan S, Siprashvili Z, Shanderson R, Hong A
Nat Genet. 2025; 57(3):718-728.
PMID: 39962238
DOI: 10.1038/s41588-024-02070-5.
Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy.
Ling S, Zhang X, Dai Y, Jiang Z, Zhou X, Lu S
Nat Nanotechnol. 2025; .
PMID: 39930103
DOI: 10.1038/s41565-024-01851-7.
Ancient origin and high diversity of zymocin-like killer toxins in the budding yeast subphylum.
Heneghan P, Salzberg L, O Cinneide E, Dewald J, Weinberg C, Wolfe K
Proc Natl Acad Sci U S A. 2025; 122(7):e2419860122.
PMID: 39928860
PMC: 11848437.
DOI: 10.1073/pnas.2419860122.
Functional screen identifies RBM42 as a mediator of oncogenic mRNA translation specificity.
Kovalski J, Sarioglu G, Subramanyam V, Hernandez G, Rademaker G, Oses-Prieto J
Nat Cell Biol. 2025; 27(3):518-529.
PMID: 39905246
DOI: 10.1038/s41556-024-01604-7.
The assembly factor Reh1 is released from the ribosome during its initial round of translation.
Musalgaonkar S, Yelland J, Chitale R, Rao S, Ozadam H, Taylor D
Nat Commun. 2025; 16(1):1278.
PMID: 39900920
PMC: 11791190.
DOI: 10.1038/s41467-025-55844-8.
Early tolerance and late persistence as alternative drug responses in cancer.
Punzi S, Cittaro D, Gatti G, Crupi G, Botrugno O, Cartalemi A
Nat Commun. 2025; 16(1):1291.
PMID: 39900637
PMC: 11790948.
DOI: 10.1038/s41467-024-54728-7.